Asciminib is a drug used for CML that doesn’t respond to other treatments. It’s made to hit the ABL myristoyl pocket, which is really important for the BCR-ABL kinase to work. You can get this drug in two sizes: 20 mg and 40 mg tablets with a coating.
Most folks take 80 mg of this stuff once a day, or 40 mg two times a day. It comes in bottles with 60 tablets each. It’s a kind of medicine that blocks the BCR-ABL kinase, used for CML patients who didn’t get better with other treatments.
The tablets are made so people will take them right, and the once-a-day or twice-a-day schedule is easier to follow. Healthcare providers need to watch patients closely when they’re on Asciminib, because there could be side effects or drug mix-ups to deal with. This is like a generic version of other BCR-ABL inhibitors, and it’s meant to work just as well as the brand-name stuff.
